Industry: Pharma & Healthcare
Published Date: 2025-03-13
Pages: 92 Pages
Report ld: 4667636
Request Sample
Customized Report
Dry Powder Inhalation Excipients Market Size(US$)

CAGR 2025-2031
5.4%
Market Size,2031
USD 2,491
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Dry Powder Inhalation Excipients market size was US$ 1733 million in 2024 and is forecast to a readjusted size of US$ 2491 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Dry powder inhalation excipients are auxiliary components used in dry powder inhalation formulations to improve drug dispersion, stability, and inhalation performance. They typically include lactose, mannitol, and other sugars, as well as certain inorganic salts. By optimizing the particle size and distribution of the drug, these excipients enhance the lung deposition rate and bioavailability of the drug. Dry powder inhalation excipients play a crucial role in the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease, ensuring effective drug inhalation and therapeutic effects.
The North America Dry Powder Inhalation Excipients market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of Dry Powder Inhalation Excipients include Protheragen-ING, DFE Pharma, Meggle-Pharma, Pfanstiehl, Merck, Sheffield (Kerry), Armor Pharma, Abbott, Norvatis, Bayer, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Dry Powder Inhalation Excipients market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Dry Powder Inhalation Excipients market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Magnesium Stearate in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., MDI in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Lactose dominance in Europe vs. Magnesium Stearate demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Dry Powder Inhalation Excipients Product Scope
1.2 Dry Powder Inhalation Excipients by Type
1.2.1 Global Dry Powder Inhalation Excipients Sales by Type (2020 & 2024 & 2031)
1.2.2 Lactose
1.2.3 Magnesium Stearate
1.2.4 Others
1.3 Dry Powder Inhalation Excipients by Application
1.3.1 Global Dry Powder Inhalation Excipients Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 DPI
1.3.3 MDI
1.3.4 Nebulizer
1.3.5 Others
1.4 Global Dry Powder Inhalation Excipients Market Estimates and Forecasts (2020-2031)
1.4.1 Global Dry Powder Inhalation Excipients Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Dry Powder Inhalation Excipients Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Dry Powder Inhalation Excipients Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Dry Powder Inhalation Excipients Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Dry Powder Inhalation Excipients Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Dry Powder Inhalation Excipients Sales Market Share by Region (2020-2025)
2.2.2 Global Dry Powder Inhalation Excipients Revenue Market Share by Region (2020-2025)
2.3 Global Dry Powder Inhalation Excipients Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Dry Powder Inhalation Excipients Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Dry Powder Inhalation Excipients Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Dry Powder Inhalation Excipients Market Size and Prospective (2020-2031)
2.4.2 Europe Dry Powder Inhalation Excipients Market Size and Prospective (2020-2031)
2.4.3 China Dry Powder Inhalation Excipients Market Size and Prospective (2020-2031)
2.4.4 Japan Dry Powder Inhalation Excipients Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Dry Powder Inhalation Excipients Historic Market Review by Type (2020-2025)
3.1.1 Global Dry Powder Inhalation Excipients Sales by Type (2020-2025)
3.1.2 Global Dry Powder Inhalation Excipients Revenue by Type (2020-2025)
3.1.3 Global Dry Powder Inhalation Excipients Price by Type (2020-2025)
3.2 Global Dry Powder Inhalation Excipients Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Dry Powder Inhalation Excipients Sales Forecast by Type (2026-2031)
3.2.2 Global Dry Powder Inhalation Excipients Revenue Forecast by Type (2026-2031)
3.2.3 Global Dry Powder Inhalation Excipients Price Forecast by Type (2026-2031)
3.3 Different Types Dry Powder Inhalation Excipients Representative Players
4 Global Market Size by Application
4.1 Global Dry Powder Inhalation Excipients Historic Market Review by Application (2020-2025)
4.1.1 Global Dry Powder Inhalation Excipients Sales by Application (2020-2025)
4.1.2 Global Dry Powder Inhalation Excipients Revenue by Application (2020-2025)
4.1.3 Global Dry Powder Inhalation Excipients Price by Application (2020-2025)
4.2 Global Dry Powder Inhalation Excipients Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Dry Powder Inhalation Excipients Sales Forecast by Application (2026-2031)
4.2.2 Global Dry Powder Inhalation Excipients Revenue Forecast by Application (2026-2031)
4.2.3 Global Dry Powder Inhalation Excipients Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Dry Powder Inhalation Excipients Application
5 Competition Landscape by Players
5.1 Global Dry Powder Inhalation Excipients Sales by Players (2020-2025)
5.2 Global Top Dry Powder Inhalation Excipients Players by Revenue (2020-2025)
5.3 Global Dry Powder Inhalation Excipients Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Powder Inhalation Excipients as of 2024)
5.4 Global Dry Powder Inhalation Excipients Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Dry Powder Inhalation Excipients, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Dry Powder Inhalation Excipients, Product Type & Application
5.7 Global Key Manufacturers of Dry Powder Inhalation Excipients, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Dry Powder Inhalation Excipients Sales by Company
6.1.1.1 North America Dry Powder Inhalation Excipients Sales by Company (2020-2025)
6.1.1.2 North America Dry Powder Inhalation Excipients Revenue by Company (2020-2025)
6.1.2 North America Dry Powder Inhalation Excipients Sales Breakdown by Type (2020-2025)
6.1.3 North America Dry Powder Inhalation Excipients Sales Breakdown by Application (2020-2025)
6.1.4 North America Dry Powder Inhalation Excipients Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Dry Powder Inhalation Excipients Sales by Company
6.2.1.1 Europe Dry Powder Inhalation Excipients Sales by Company (2020-2025)
6.2.1.2 Europe Dry Powder Inhalation Excipients Revenue by Company (2020-2025)
6.2.2 Europe Dry Powder Inhalation Excipients Sales Breakdown by Type (2020-2025)
6.2.3 Europe Dry Powder Inhalation Excipients Sales Breakdown by Application (2020-2025)
6.2.4 Europe Dry Powder Inhalation Excipients Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Dry Powder Inhalation Excipients Sales by Company
6.3.1.1 China Dry Powder Inhalation Excipients Sales by Company (2020-2025)
6.3.1.2 China Dry Powder Inhalation Excipients Revenue by Company (2020-2025)
6.3.2 China Dry Powder Inhalation Excipients Sales Breakdown by Type (2020-2025)
6.3.3 China Dry Powder Inhalation Excipients Sales Breakdown by Application (2020-2025)
6.3.4 China Dry Powder Inhalation Excipients Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Dry Powder Inhalation Excipients Sales by Company
6.4.1.1 Japan Dry Powder Inhalation Excipients Sales by Company (2020-2025)
6.4.1.2 Japan Dry Powder Inhalation Excipients Revenue by Company (2020-2025)
6.4.2 Japan Dry Powder Inhalation Excipients Sales Breakdown by Type (2020-2025)
6.4.3 Japan Dry Powder Inhalation Excipients Sales Breakdown by Application (2020-2025)
6.4.4 Japan Dry Powder Inhalation Excipients Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Protheragen-ING
7.1.1 Protheragen-ING Company Information
7.1.2 Protheragen-ING Business Overview
7.1.3 Protheragen-ING Dry Powder Inhalation Excipients Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Protheragen-ING Dry Powder Inhalation Excipients Products Offered
7.1.5 Protheragen-ING Recent Development
7.2 DFE Pharma
7.2.1 DFE Pharma Company Information
7.2.2 DFE Pharma Business Overview
7.2.3 DFE Pharma Dry Powder Inhalation Excipients Sales, Revenue and Gross Margin (2020-2025)
7.2.4 DFE Pharma Dry Powder Inhalation Excipients Products Offered
7.2.5 DFE Pharma Recent Development
7.3 Meggle-Pharma
7.3.1 Meggle-Pharma Company Information
7.3.2 Meggle-Pharma Business Overview
7.3.3 Meggle-Pharma Dry Powder Inhalation Excipients Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Meggle-Pharma Dry Powder Inhalation Excipients Products Offered
7.3.5 Meggle-Pharma Recent Development
7.4 Pfanstiehl
7.4.1 Pfanstiehl Company Information
7.4.2 Pfanstiehl Business Overview
7.4.3 Pfanstiehl Dry Powder Inhalation Excipients Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Pfanstiehl Dry Powder Inhalation Excipients Products Offered
7.4.5 Pfanstiehl Recent Development
7.5 Merck
7.5.1 Merck Company Information
7.5.2 Merck Business Overview
7.5.3 Merck Dry Powder Inhalation Excipients Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Merck Dry Powder Inhalation Excipients Products Offered
7.5.5 Merck Recent Development
7.6 Sheffield (Kerry)
7.6.1 Sheffield (Kerry) Company Information
7.6.2 Sheffield (Kerry) Business Overview
7.6.3 Sheffield (Kerry) Dry Powder Inhalation Excipients Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Sheffield (Kerry) Dry Powder Inhalation Excipients Products Offered
7.6.5 Sheffield (Kerry) Recent Development
7.7 Armor Pharma
7.7.1 Armor Pharma Company Information
7.7.2 Armor Pharma Business Overview
7.7.3 Armor Pharma Dry Powder Inhalation Excipients Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Armor Pharma Dry Powder Inhalation Excipients Products Offered
7.7.5 Armor Pharma Recent Development
7.8 Abbott
7.8.1 Abbott Company Information
7.8.2 Abbott Business Overview
7.8.3 Abbott Dry Powder Inhalation Excipients Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Abbott Dry Powder Inhalation Excipients Products Offered
7.8.5 Abbott Recent Development
7.9 Norvatis
7.9.1 Norvatis Company Information
7.9.2 Norvatis Business Overview
7.9.3 Norvatis Dry Powder Inhalation Excipients Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Norvatis Dry Powder Inhalation Excipients Products Offered
7.9.5 Norvatis Recent Development
7.10 Bayer
7.10.1 Bayer Company Information
7.10.2 Bayer Business Overview
7.10.3 Bayer Dry Powder Inhalation Excipients Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Bayer Dry Powder Inhalation Excipients Products Offered
7.10.5 Bayer Recent Development
7.11 Jiangsu Daoning Drug
7.11.1 Jiangsu Daoning Drug Company Information
7.11.2 Jiangsu Daoning Drug Business Overview
7.11.3 Jiangsu Daoning Drug Dry Powder Inhalation Excipients Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Jiangsu Daoning Drug Dry Powder Inhalation Excipients Products Offered
7.11.5 Jiangsu Daoning Drug Recent Development
8 Dry Powder Inhalation Excipients Manufacturing Cost Analysis
8.1 Dry Powder Inhalation Excipients Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Dry Powder Inhalation Excipients
8.4 Dry Powder Inhalation Excipients Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Dry Powder Inhalation Excipients Distributors List
9.3 Dry Powder Inhalation Excipients Customers
10 Dry Powder Inhalation Excipients Market Dynamics
10.1 Dry Powder Inhalation Excipients Industry Trends
10.2 Dry Powder Inhalation Excipients Market Drivers
10.3 Dry Powder Inhalation Excipients Market Challenges
10.4 Dry Powder Inhalation Excipients Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Dry Powder Inhalation Excipients market is projected to grow from US$ 1817 million in 2025 to US$ 2613 million by 2032, at a CAGR of 5.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 159
USD 4900.00
(Single User License)
The global Dry Powder Inhalation Excipients market size was US$ 1817 million in 2025 and is forecast to reach a readjusted size of US$ 2613 million by 2032 with a CAGR of 5.4% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 99
USD 4250.00
(Single User License)
The global market for Dry Powder Inhalation Excipients was estimated to be worth US$ 1817 million in 2025 and is projected to reach US$ 2613 million, growing at a CAGR of 5.4% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 123
USD 3950.00
(Single User License)
The global Dry Powder Inhalation Excipients market was valued at US$ 1817 million in 2025 and is anticipated to reach US$ 2613 million by 2032, at a CAGR of 5.4% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 124
USD 2900.00
(Single User License)
The global Dry Powder Inhalation Excipients market is projected to grow from US$ 1733 million in 2024 to US$ 2491 million by 2031, at a CAGR of 5.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 159
USD 4900.00
(Single User License)
The global market for Dry Powder Inhalation Excipients was estimated to be worth US$ 1733 million in 2024 and is forecast to a readjusted size of US$ 2491 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 127
USD 3950.00
(Single User License)
The global market for Dry Powder Inhalation Excipients was valued at US$ 1733 million in the year 2024 and is projected to reach a revised size of US$ 2491 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Published Date: 2025-03-13
Pages: 97
USD 2900.00
(Single User License)
The global Dry Powder Inhalation Excipients revenue was US$ 1674 million in 2023 and is forecast to a readjusted size of US$ 2376 million by 2030 with a CAGR of 5.4% during the review period (2024-2030).
Published Date: 2025-01-01
Pages: 133
USD 4350.00
(Single User License)
The global market for Dry Powder Inhalation Excipients was valued at US$ 1674 million in the year 2023 and is projected to reach a revised size of US$ 2376 million by 2030, growing at a CAGR of 5.4% during the forecast period.
Published Date: 2025-01-01
Pages: 91
USD 2900.00
(Single User License)
The global market for Dry Powder Inhalation Excipients was estimated to be worth US$ 1674 million in 2023 and is forecast to a readjusted size of US$ 2376 million by 2030 with a CAGR of 5.4% during the forecast period 2024-2030.
Published Date: 2025-01-01
Pages: 117
USD 3950.00
(Single User License)
The global Dry Powder Inhalation Excipients market is projected to grow from US$ 1817 million in 2025 to US$ 2613 million by 2032, at a CAGR of 5.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 159
The global Dry Powder Inhalation Excipients market size was US$ 1817 million in 2025 and is forecast to reach a readjusted size of US$ 2613 million by 2032 with a CAGR of 5.4% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 99
The global market for Dry Powder Inhalation Excipients was estimated to be worth US$ 1817 million in 2025 and is projected to reach US$ 2613 million, growing at a CAGR of 5.4% from 2026 to 2032.
Published: 2026-01-19
Pages: 123
The global Dry Powder Inhalation Excipients market was valued at US$ 1817 million in 2025 and is anticipated to reach US$ 2613 million by 2032, at a CAGR of 5.4% from 2026 to 2032.
Published: 2026-01-08
Pages: 124
The global Dry Powder Inhalation Excipients market is projected to grow from US$ 1733 million in 2024 to US$ 2491 million by 2031, at a CAGR of 5.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 159
The global market for Dry Powder Inhalation Excipients was estimated to be worth US$ 1733 million in 2024 and is forecast to a readjusted size of US$ 2491 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 127
The global market for Dry Powder Inhalation Excipients was valued at US$ 1733 million in the year 2024 and is projected to reach a revised size of US$ 2491 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Published: 2025-03-13
Pages: 97
The global Dry Powder Inhalation Excipients revenue was US$ 1674 million in 2023 and is forecast to a readjusted size of US$ 2376 million by 2030 with a CAGR of 5.4% during the review period (2024-2030).
Published: 2025-01-01
Pages: 133
The global market for Dry Powder Inhalation Excipients was valued at US$ 1674 million in the year 2023 and is projected to reach a revised size of US$ 2376 million by 2030, growing at a CAGR of 5.4% during the forecast period.
Published: 2025-01-01
Pages: 91
The global market for Dry Powder Inhalation Excipients was estimated to be worth US$ 1674 million in 2023 and is forecast to a readjusted size of US$ 2376 million by 2030 with a CAGR of 5.4% during the forecast period 2024-2030.
Published: 2025-01-01
Pages: 117
REPORT COVERAGE
DESCRIPTION
MARKET SEGMENTATION
Why This Report?
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now